KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Long-Term Deferred Tax (2016 - 2025)

Abbott Laboratories' Long-Term Deferred Tax history spans 15 years, with the latest figure at $17.3 billion for Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 116.18% year-over-year to $17.3 billion; the TTM value through Sep 2025 reached $17.3 billion, up 116.18%, while the annual FY2024 figure was $16.5 billion, 131.91% up from the prior year.
  • Long-Term Deferred Tax for Q3 2025 was $17.3 billion at Abbott Laboratories, roughly flat from $17.3 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $17.3 billion in Q3 2025 and bottomed at $3.7 billion in Q1 2021.
  • The 5-year median for Long-Term Deferred Tax is $6.5 billion (2023), against an average of $8.2 billion.
  • The largest annual shift saw Long-Term Deferred Tax increased 7.95% in 2021 before it surged 131.91% in 2024.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $5.2 billion in 2021, then increased by 15.75% to $6.0 billion in 2022, then increased by 17.64% to $7.1 billion in 2023, then soared by 131.91% to $16.5 billion in 2024, then rose by 5.22% to $17.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Long-Term Deferred Tax are $17.3 billion (Q3 2025), $17.3 billion (Q2 2025), and $16.8 billion (Q1 2025).